Jazz Pharmaceuticals (JAZZ) Return on Invested Capital Growth (5y) (2017 - 2026)

Jazz Pharmaceuticals (JAZZ) Return on Invested Capital Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Jazz Pharmaceuticals 15.75 Bn 13.91 Bn 934.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.00
Dec 31, 2025 -1.00
Sep 30, 2025 -1.00
Jun 30, 2025 -2.00
Mar 31, 2025 -3.00
Dec 31, 2024 -4.00
Sep 30, 2024 -5.00
Jun 30, 2024 -5.00
Mar 31, 2024 -4.00
Dec 31, 2023 -3.00
Sep 30, 2023 -4.00
Jun 30, 2023 -3.00
Mar 31, 2023 -3.00
Dec 31, 2022 -3.00
Sep 30, 2022 -2.00
Jun 30, 2022 -1.00
Mar 31, 2022 -2.00
Dec 31, 2021 -2.00
Sep 30, 2021 -3.00
Jun 30, 2021 -2.00